Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2.
about
S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motilityImpacts of tissue-type plasminogen activator (tPA) on neuronal survivaltPA is a potent mitogen for renal interstitial fibroblasts: role of beta1 integrin/focal adhesion kinase signalingProgastrin Peptides Increase the Risk of Developing Colonic Tumors: Impact on Colonic Stem CellsHuman epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cellsActivated protein C enhances cell motility of endothelial cells and MDA-MB-231 breast cancer cells by intracellular signal transduction.Revealing the molecular mechanism of gastric cancer marker annexin A4 in cancer cell proliferation using exon arraysInhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies.Tissue plasminogen activator prevents white matter damage following stroke.Clathrin mediates endocytosis of progastrin and activates MAPKs: role of cell surface annexin A2.Tissue plasminogen activator activates NF-κB through a pathway involving annexin A2/CD11b and integrin-linked kinase.Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitisNovel actions of tissue-type plasminogen activator in chronic kidney disease.Annexin A4 is involved in proliferation, chemo-resistance and migration and invasion in ovarian clear cell adenocarcinoma cells.Urine annexin A1 as an index for glomerular injury in patients.α-Enolase: a promising therapeutic and diagnostic tumor target.Tissue plasminogen activator and inflammation: from phenotype to signaling mechanisms.From plasminogen to plasmin: role of plasminogen receptors in human cancer.PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.Binding of tissue-type plasminogen activator to the glucose-regulated protein 78 (GRP78) modulates plasminogen activation and promotes human neuroblastoma cell proliferation in vitro.Tissue-type plasminogen activator deficiency delays bone repair: roles of osteoblastic proliferation and vascular endothelial growth factor.Bioinformatic and experimental fishing for artemisinin-interacting proteins from human nasopharyngeal cancer cells.Matrilysin (matrix metalloprotease-7) cleaves membrane-bound annexin II and enhances binding of tissue-type plasminogen activator to cancer cell surfaces.Activation of NF-kappaB is required for mediating proliferative and antiapoptotic effects of progastrin on proximal colonic crypts of mice, in vivo.Ligand binding to LRP1 transactivates Trk receptors by a Src family kinase-dependent pathway.Annexin A2 mediates up-regulation of NF-κB, β-catenin, and stem cell in response to progastrin in mice and HEK-293 cells.Grassystatins D-F, Potent Aspartic Protease Inhibitors from Marine Cyanobacteria as Potential Antimetastatic Agents Targeting Invasive Breast Cancer.Tissue plasminogen activator induces microglial inflammation via a noncatalytic molecular mechanism involving activation of mitogen-activated protein kinases and Akt signaling pathways and AnnexinA2 and Galectin-1 receptors.Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer.
P2860
Q24311937-4F1B6197-136B-4AFD-A95B-E140C40DCC50Q26777261-6CA91945-D4EB-4874-98F5-D228A1790BA2Q28564568-5D15D838-7E37-45DF-B189-433CD51FDD4AQ30424597-9BABFBB2-EF98-4DEC-BF22-18E65A3B1F6FQ30597866-C5B38946-8A11-4D47-AED9-6D8B6F764436Q33615455-C6161E40-4DAA-4E9D-B837-7ECF5D909B1EQ34412619-03A9915F-1FAA-4BBF-9E66-51CF3C1F2954Q34687047-45482A8D-8584-4EBD-94AC-E5ED208C00B1Q35213585-5C045C3A-9539-4720-B9EC-FD7C972724B2Q35900882-08185DB4-1220-4A24-BC94-F1DC52887824Q36109173-6C21E11F-8344-4520-8B8B-E8EF51174938Q36280897-D3A23468-B763-4F00-85E5-B5D1C9B24AC4Q37115034-97807936-FD23-4E3F-ABE7-1FB7D671FA0EQ37296914-FF96387A-6797-4603-A0E2-40638A3E6688Q37586797-CC6ADB16-B106-4B8A-9D83-3C7DB3E97693Q37831975-73A37AF1-B4F0-4700-B30B-A426F4D069F8Q38198639-081C4CB2-9640-41DA-8873-AF2A0BE887B5Q38269342-0CBC4FAE-F085-4DA9-86BB-B07EA013B999Q38798369-0483893A-5B46-4101-AB5A-D6213E901794Q38869978-1752573E-DC02-443A-BF97-C50BB92C9B06Q38972005-36C4C291-2870-431A-87E6-4BADA99F4F31Q38985924-808BD501-6526-4123-8AB2-AA468E00B4B2Q39400558-9D42E6F6-4425-4644-A7D3-E9665B5B0BEAQ39948157-E1484E31-9835-4138-96D8-CE3323ED0E4DQ41411959-A8591096-A87E-4994-8932-FC96B6326F74Q41470171-E4468F69-1A17-4B0A-8590-E056CE2C45A3Q42586822-B6AF1358-A46E-4BD0-AA8B-1E7D1BF4C54FQ47583201-CD105E41-63A7-42AE-A2A7-8D488665483CQ48786061-0D629F60-E36F-4875-AAA8-F92E283246F8Q53205814-82C789AE-8943-4E42-B03F-C1847E16EDFEQ54993659-4D1B3ED8-05CA-44E8-A313-924025128378
P2860
Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tissue plasminogen activator i ...... actor receptor and annexin A2.
@en
type
label
Tissue plasminogen activator i ...... actor receptor and annexin A2.
@en
prefLabel
Tissue plasminogen activator i ...... actor receptor and annexin A2.
@en
P2093
P2860
P1476
Tissue plasminogen activator i ...... actor receptor and annexin A2.
@en
P2093
Coral Ampurdanés
Elena Ortiz-Zapater
Josep M Corominas
Oriol Roda
Sandra Peiró
Susana Aguilar
P2860
P304
P356
10.2353/AJPATH.2007.060850
P407
P577
2007-05-01T00:00:00Z